Literature DB >> 16807754

Influence of anatomy and head position on intranasal drug deposition.

Paul Merkus1, Fenna A Ebbens, Barbara Muller, Wytske J Fokkens.   

Abstract

The objective of this study was to determine the influence of individual anatomical differences on intranasal drug deposition. The data of a comparison of seven different administration techniques in ten healthy volunteers was used in this single-blind crossover pilot study. After intranasal administration of a dyed test formulation, endoscopic video imaging was done on seven non-sequential days. The deposition pattern per individual around the head of the middle turbinate was analyzed for each technique and correlated with the individual anatomy. Decreased deposition of dyed test formulation in the target area around the head of the middle turbinate was observed in the presence of minor septal deviations, narrow nasal valve areas, or inferior turbinate hypertrophy; a lateral head position helps to bypass a minor septal deviation. Although results are preliminary, we conclude that anatomy and head position are important factors in the deposition of topical nasal drugs and may be the key to improving individual local nasal (steroid) treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807754     DOI: 10.1007/s00405-006-0071-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  20 in total

1.  Delivery of nasal drops to the middle meatus: which is the best head position?

Authors:  Y G Karagama; J L Lancaster; A Karkanevatos; G O'Sullivan
Journal:  Rhinology       Date:  2001-12       Impact factor: 3.681

2.  New method for the effective instillation of nasal drops.

Authors:  U Raghavan; B M Logan
Journal:  J Laryngol Otol       Date:  2000-06       Impact factor: 1.469

Review 3.  The assessment of topical nasal drug distribution.

Authors:  R Aggarwal; A Cardozo; J J Homer
Journal:  Clin Otolaryngol Allied Sci       Date:  2004-06

4.  The 'best method' of topical nasal drug delivery: comparison of seven techniques.

Authors:  P Merkus; F A Ebbens; B Muller; W J Fokkens
Journal:  Rhinology       Date:  2006-06       Impact factor: 3.681

5.  An evaluation of the best head position for instillation of steroid nose drops.

Authors:  R Kayarkar; N J Clifton; T J Woolford
Journal:  Clin Otolaryngol Allied Sci       Date:  2002-02

6.  Effect of fluticasone in severe polyposis.

Authors:  V J Lund; J Flood; A P Sykes; D H Richards
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-05

7.  Intranasal drug delivery by spray and drops.

Authors:  J G Hardy; S W Lee; C G Wilson
Journal:  J Pharm Pharmacol       Date:  1985-05       Impact factor: 3.765

8.  Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery.

Authors:  Albertien A C Aukema; Paul G H Mulder; Wytske J Fokkens
Journal:  J Allergy Clin Immunol       Date:  2005-05       Impact factor: 10.793

9.  A comparative distribution study of two procedures for administration of nose drops.

Authors:  F Morén; K Björnek; T Klint; Z G Wagner
Journal:  Acta Otolaryngol       Date:  1988 Sep-Oct       Impact factor: 1.494

10.  Techniques of intranasal steroid use.

Authors:  Michael S Benninger; James A Hadley; J David Osguthorpe; Bradley F Marple; Donald A Leopold; M Jennifer Derebery; Maureen Hannley
Journal:  Otolaryngol Head Neck Surg       Date:  2004-01       Impact factor: 5.591

View more
  21 in total

1.  Septoplasty and decongestant improve distribution of nasal spray.

Authors:  Jiaoping Mi; Yunping Fan; Shaoyan Feng; Wentong Xia; Jingqing Wang; Huabin Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

Review 2.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

3.  Role of inferior turbinate reduction in the quality of life of patients undergoing endoscopic sinus surgery for chronic rhinosinusitis.

Authors:  Ethan Soudry; Jess Mace; Timothy L Smith; Peter H Hwang
Journal:  Int Forum Allergy Rhinol       Date:  2019-06-20       Impact factor: 3.858

4.  A response to the opioid overdose epidemic: naloxone nasal spray.

Authors:  Daniel P Wermeling
Journal:  Drug Deliv Transl Res       Date:  2013-02-01       Impact factor: 4.617

Review 5.  Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches.

Authors:  Niyanta N Kumar; Michelle E Pizzo; Geetika Nehra; Brynna Wilken-Resman; Sam Boroumand; Robert G Thorne
Journal:  Bioconjug Chem       Date:  2018-10-24       Impact factor: 4.774

6.  Effects of anatomy and particle size on nasal sprays and nebulizers.

Authors:  Dennis O Frank; Julia S Kimbell; Sachin Pawar; John S Rhee
Journal:  Otolaryngol Head Neck Surg       Date:  2011-11-02       Impact factor: 3.497

7.  Efficacy and safety of delivery of topical medication on to the frontal sinus at different head positions after frontal sinusotomy.

Authors:  Yu-Xiao Wu; Min Wang; Hui Li; Zhi-Min Xing; Mu-Han Shi; Shi-En Huang; Yan Liu; Cong-Li Geng
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-02-13       Impact factor: 2.503

Review 8.  A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.

Authors:  Marilena M DeMayo; Yun Ju C Song; Ian B Hickie; Adam J Guastella
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

9.  Deviated nasal septum hinders intranasal sprays: a computer simulation study.

Authors:  D O Frank; J S Kimbell; D Cannon; S S Pawar; J S Rhee
Journal:  Rhinology       Date:  2012-09       Impact factor: 3.681

10.  Computed intranasal spray penetration: comparisons before and after nasal surgery.

Authors:  Dennis O Frank; Julia S Kimbell; Daniel Cannon; John S Rhee
Journal:  Int Forum Allergy Rhinol       Date:  2012-08-27       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.